Article Text

other Versions

PDF
Large scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis
  1. Michael A van Es1,
  2. Caroline Dahlberg2,
  3. Anna Birve2,
  4. Jan Herman Veldink3,
  5. L H Van den van den Berg4,*,
  6. P M Andersen5
  1. 1 UMC Utrecht, Netherlands;
  2. 2 Umeå University Hospital, Umeå, Sweden;
  3. 3 University Medical Center Utrecht, Netherlands;
  4. 4 University Hospital Utrecht, THE NETHERLANDS;
  5. 5 Ume University Hospital, Sweden
  1. Correspondence to: L H Van den van den Berg, University Hospital Utrecht, Department of Neurology, University Hospital Utrecht, G03.228, PO Box 85500, 3508 GA Utrecht, THE NETHERLANDS; lberg{at}umcutrecht.nl

Abstract

Objective: To estimate the frequency of SOD1 mutations in a large referral cohort of familial ALS and sporadic ALS patients from The Netherlands and to compare this frequency to other developed countries.

Methods: A total of 451 sporadic and 55 familial ALS patients were screened for SOD1 mutations. We performed PCR amplification of all five coding exons of SOD1 followed by direct DNA sequencing using forward and reverse primers.

Results: One novel mutation (p.I99V) and a homozygous p.D90A mutation were identified in sporadic ALS patients. In a pedigree with Mendelian dominant FALS one patient was found to be heterozygous for the p.D90A mutation. SOD1 mutation frequency was found to be significantly lower in The Netherlands compared to other countries with p = 0.0004 for FALS (21.9 % versus 2.5 %) and p = 0.005 for SALS (2.5 % versus 0.44%).

Conclusions: We demonstrate that SOD1 mutations are rare in the Netherlands in familial and sporadic ALS. This observation suggests that the genetic background of ALS differs between different populations, countries and regions. This may have consequences for the interpretation of association studies and explain why replication of association studies has proven difficult in ALS.

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.